Search - tctmd.com

Displaying 41 - 60 of 310

Sort: Relevancy | Date

Presentation NY Valves 2024

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Presenter: Azeem Latib

June 06, 2024

Presentation NY Valves 2024

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

Presenter: Jörg Hausleiter

June 06, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

Presenter: Charles J. Davidson

June 06, 2024

Presentation NY Valves 2024

TRILUMINATE: Looking Beyond the Headlines – What Lessons Have We Learned?

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

Case Presentation 1: T-TEER With TriClip in a Patient With Atrial Functional TR

Presenter: Matthew J. Price

June 06, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Industry News

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

May 08, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Industry News

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

April 03, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Todd Neale

March 29, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

News Daily News

Bempedoic Acid Gains CV Risk Reduction Indication

Todd Neale

March 22, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

Todd Neale

March 08, 2024

News Daily News

Semaglutide Winning Streak Continues in CKD With FLOW

Shelley Wood

March 06, 2024

Presentation THT 2024

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Presenter: Scott Solomon

March 04, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

Advertisement

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

Introducing Novel Transcatheter Tricuspid Therapies: What Can the Early European Experience With TTVI Teach Us?

TRISCEND II: Understanding the Study Design and Interpreting the Results

Case Presentation 2: Transcatheter Tricuspid Valve Replacement With Evoque in a Patient With CIED-Related TR

TRILUMINATE: Looking Beyond the Headlines – What Lessons Have We Learned?

Case Presentation 1: T-TEER With TriClip in a Patient With Atrial Functional TR

June 2024 Dispatch for the CV Team

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

FDA Approves Bioresorbable Scaffold for BTK Lesions

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

FDA Approves TriClip TEER Device for Tricuspid Repair

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Biologic Winrevair Wins FDA Approval for Treatment of PAH

Bempedoic Acid Gains CV Risk Reduction Indication

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

FDA Grants MACE Reduction Indication for Semaglutide

Semaglutide Winning Streak Continues in CKD With FLOW

The Future of Heart Failure Trials: Faster, Better and More Efficient Approaches to Approvals

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content